|AHFS/Drugs.com||Micromedex Detailed Consumer Information|
|Oral (tablets, syrup), inhalation (DPI)|
|ATC code||R03AC16 (WHO) R03CC08 (WHO)|
|Chemical and physical data|
|Molar mass||290.357 g/mol|
|3D model (Jmol)||Interactive image|
|(what is this?)|
Procaterol, applied as procaterol hydrochloride (USAN), is an intermediate-acting β2 adrenoreceptor agonist used for the treatment of asthma. It has never been filed for FDA evaluation in the United States, where it is not marketed. The drug is readily oxidized in the presence of moisture and air, making it unsuitable for therapeutic use by inhalation. Pharmaceutical company Parke-Davis/Warner-Lambert researched a stabilizer to prevent oxidation, but an effective one was never developed.
Like pirbuterol, procaterol exhibits similar broncholytic properties as salbutamol (albuterol), but it has somewhat of a more prolonged action. It is recommended for use as an inhaled drug for treating asthma.
8-Hydroxycarbostyril 1 is acylated with 2-bromobutyric acid chloride 2 at the fifth position of the quinoline system, which gives the compound 3. This undergoes action of isopropylamine, forming an aminoketone, the carbonyl group of which is reduced by sodium borohydride, giving procaterol 4.
- US, "Procaterol stabilization", published 1984, issued 1986
- K. Nakagawa, S. Yoshizaki, U.S. Patent 4,026,897 (1977).
- S. Yoshizaki, M. Osaki, K. Nakagawa, Y. Yamura, Chem. Pharm. Bull., 28, 3441 (1980).
- Yoshizaki, Shiro; Tanimura, Kaoru; Tamada, Shigeharu; Yabuuchi, Youichi; Nakagawa, Kazuyuki (1976). "Sympathomimetic amines having a carbostyril nucleus". Journal of Medicinal Chemistry. 19 (9): 1138. doi:10.1021/jm00231a011. PMID 10441.
- Yoshizaki, Shiro; Manabe, Yoshiaki; Tamada, Shigeharu; Nakagawa, Kazuyuki; Tei, Seiso (1977). "Isomers of erythro-5-(1-hydroxy-2-isopropylaminobutyl)-8-hydroxycarbostyril, a new bronchodilator". Journal of Medicinal Chemistry. 20 (8): 1103. doi:10.1021/jm00218a024. PMID 894683.
- "International Drugs: Procaterol". Drugs.com. Retrieved 7 March 2016.